Expression of NY-ESO-1 in Primary and Metastatic Melanoma

NY-ESO-1, a cancer testis antigen, is an ideal target for adoptive cell transfer immunotherapy. Evidence from several clinical trials in melanoma and other malignancies shows the potential value of targeting the NY-ESO-1 antigen in immune-based therapy of metastatic tumors. However, the incidence of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aung, Phyu P., Liu, Yen-Chun, Ballester, Leomar Y., Robbins, Paul F., Rosenberg, Steven A, Lee, Chyi-Chia Richard
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946994/
https://ncbi.nlm.nih.gov/pubmed/24290058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2013.05.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados